Publications14

..To determine the healthcare costs associated with treatment of alcohol dependence with medications versus no medication and across the 4 medications approved by the US Food and Drug Administration (FDA)...

Cost and utilization outcomes of opioid-dependence treatments

Onur BaserTATinMED Research and the University of Michigan, USAAm J Manag Care 17:S235-48. 2011

..To evaluate the healthcare costs associated with treatment of opioid-dependence disorder with medications versus no medication, and with the 4 agents approved by the US Food and Drug Administration (FDA)...

..While more research is needed, current findings suggest that a formulation of naltrexone that was sought beginning over three decades ago is fulfilling its promise as an extended-release pharmacotherapeutic...

Reduction in heavy drinking as a treatment outcome in alcohol dependence

..This article summarizes those findings by identifying a number of critical themes related to advancing SUD pharmacotherapy performance measures, highlighting examples from the field, and recommending actions for policy makers...

Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone

..Alcohol dependence treatment may include medications, behavioral therapies, or both. It is unknown how combining these treatments may impact their effectiveness, especially in the context of primary care and other nonspecialty settings...

Early treatment response in alcohol dependence with extended-release naltrexone

..Gastfriend; (5) System Challenges in the Adoption of Pharmacotherapy, by Robert M. Swift; and (6) Pharmacotherapy for Alcohol Dependence: Strengths, Challenges, and Future Directions, by Mark L. Willenbring...

The ASAM patient placement criteria: context, concepts and continuing development